Pauls Dietrich John

Pauls Dietrich John is listed in filings as President & CEO at DiaMedica Therapeutics Inc.. This profile follows SEC Form 4 activity through Jun 3, 2025, including 1 public disclosure. Recent filings connect the profile to DiaMedica Therapeutics Inc. (DMAC). The current snapshot covers public activity from Jun 3, 2025. Reported amounts are shown as $2.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.